Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 266-946-3 | CAS number: 67701-28-4 This substance is identified by SDA Substance Name: C8-C18 and C18 unsaturated trialkyl glyceride and SDA Reporting Number: 01-001-00.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
No bioaccumulation of ‘glycerides, C8-18 and C18-unsatd. (SDA Reporting Number: 01-001-00)’
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
‘Glycerides, C8-18 and C18-unsatd. (SDA Reporting Number: 01-001-00)’ is composed mainly of triglycerides containing a glycerol backbone and linear fatty acids with a carbon chain length of C8-18 as well as unsaturated C18 fatty acids. The other known constituents are mono- and di-glycerides as well as free fatty acids. The toxicokinetics of glycerides and fatty acids are well known as a result of their widespread use in nutritional (food and feed), cosmetic and industrial applications for example.
When taken up orally, triglycerides are split in the intestinal lumen into glycerol and fatty acids with the help of lipases and bile secretions (in a process called lipolysis), then move into the cells lining the intestines (absorptive enterocytes). The triglycerides are rebuilt in the enterocytes from their fragments and packaged together with cholesterol and proteins to form chylomicrons. These are excreted from the cells, collected by the lymph system and transported to the large vessels near the heart before entering the blood. Various tissues can capture the chylomicrons, releasing the triglycerides to be used as a source of energy. When the body requires fatty acids as a source of energy, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipases to release free fatty acids from the adipose cells (fat cells), the major site of triglyceride accumulation. The fatty acids are then broken down by stepwise elimination of C2-units in the mitochondrial β-oxidation. The C2-units are esterified to acetyl-Coenzyme A which directly enters the citric acid cycle where it is converted to carbon dioxide and energy (MacDonald, 1973; Robinson, 1973; Chen and Farese, 2002).
The extent of absorption in the gastro-intestinal system varies depending on the chain length of the fatty acids and their degree of saturation. Generally, short-chain fatty acids are better absorbed than the long chain counterparts. Also, absorption decreases with increasing saturation (MacDonald, 1973; Robinson, 1973; Chen and Farese, 2002).
No experimental studies were located for absorption through the dermal route. However,as per Section R.7.12.2.1 of REACH guidance document R7.C (May 2008),the extent of dermal absorption may be predicted based on physico-chemical properties, including:
- Water solubility
- Partition coefficient
- Molecular weight / fatty acid chain length (inversely proportional)
‘Glycerides, C8-18 and C18-unsatd. (SDA Reporting Number: 01-001-00)’ is poorly water soluble (< 10 mg/L), has an estimated log Pow > 6 and a molecular weight range of 470 – 908(see Sections 1.3 and 4). As such,uptake into thestratum corneumof skin and further transfer into the epidermis are likely to be low. A default dermal penetration value of 10% can be assumed (REACH guidance document R7.C (May 2008)).
No significant inhalatoryexposure to ‘glycerides, C8-18 and C18-unsatd. (SDA Reporting Number: 01-001-00)’ will occur as the substance is semi-solid to solid under environmental conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.